LL-37 5mg (CAP-18)

Research Studies: Facilitates analysis of hCAP-18 proteolytic cleavage into biologically active LL-37 Supports investigation of FPR2-mediated chemotaxis and pro-inflammatory signaling in leukocytes Enables research on membrane permeabilization mechanisms within multidrug-resistant bacterial assays Useful for evaluating P2X7 receptor activation and NLRP3 inflammasome assembly